Results 271 to 280 of about 32,295 (302)
Some of the next articles are maybe not open access.
Clozapine for Treatment-Resistant Schizophrenia
American Journal of Therapeutics, 2016Peter, Manu, Eugene, Grudnikoff
openaire +2 more sources
[Treatment-resistant schizophrenia].
Revue medicale de Bruxelles, 2014Schizophrenia is a psychiatric disorder that causes severe cognitive, behavioral and social dysfunction, responsible for a shortening of the life expectancy of patients, with an increased risk of suicide, cardiovascular disease and cancer. The management of patient with schizophrenia is global and atypical antipsychotics, antagonizing dopamine pathway,
openaire +1 more source
Augmentation Strategies for Clozapine-Resistant Patients with Schizophrenia
Current Pharmaceutical Design, 2020Yi-Hang Chiu +2 more
exaly
Treatment resistant schizophrenia: Clinical, biological, and therapeutic perspectives
Neurobiology of Disease, 2019Frederick C Nucifora, Akira Sawa
exaly
Beneficial effects ofN-acetylcysteine in treatment resistant schizophrenia
World Journal of Biological Psychiatry, 2009Mahmut Bulut +2 more
exaly
Promising use of minocycline augmentation with clozapine in treatment-resistant schizophrenia
Journal of Psychopharmacology, 2014Nusrat Husain
exaly